Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 218

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Cancer-Associated Venous Thromboembolic Disease, Version 1.2015

Streiff, Michael B., Holmstrom, Bjorn, Ashrani, Aneel, Bockenstedt, Paula L., Chesney, Carolyn, Eby, Charles, Fanikos, John, Fenninger, Randolph B., Fogerty, Annemarie E., Gao, Shuwei, Goldhaber, Samuel Z., Hendrie, Paul, Kuderer, Nicole, Lee, Alfred, Lee, Jason T., Lovrincevic, Mirjana, Millenson, Michael M., Neff, Anne T., Ortel, Thomas L., Paschal, Rita, Shattil, Sanford, Siddiqi, Tanya, Smock, Kristi J., Soff, Gerald, Wang, Tzu-Fei, Yee, Gary C., Zakarija, Anaadriana, McMillian, Nicole, Engh, Anita M. · 2015 · Journal of the National Comprehensive Cancer Network

Abstract

The NCCN Guidelines for Cancer-Associated Venous Thromboembolic Disease outline strategies for treatment and prevention of venous thromboembolism (VTE) in adult patients with a diagnosis of cancer or for whom cancer is clinically suspected. VTE is a common complication in patients with cancer, which places them at greater risk for morbidity and mortality. Therefore, risk-appropriate prophylaxis is an essential component for the optimal care of inpatients and outpatients with cancer. Critical to meeting this goal is ensuring that patients get the most effective medication in the correct dose. Body weight has a significant impact on blood volume and drug clearance. Because obesity is a common health problem in industrialized societies, cancer care providers are increasingly likely to treat obese patients in their practice. Obesity is a risk factor common to VTE and many cancers, and may also impact the anticoagulant dose needed for safe and effective prophylaxis. These NCCN Guidelines Insights summarize the data supporting new dosing recommendations for VTE prophylaxis in obese patients with cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.6004/jnccn.2015.0133

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 218

Metadata

Authors
Streiff, M. B., Holmstrom, B., Ashrani, A., Bockenstedt, P. L., Chesney, C., Eby, C., Fanikos, J., Fenninger, R. B., Fogerty, A. E., Gao, S., Goldhaber, S. Z., Hendrie, P., Kuderer, N., Lee, A., Lee, J. T., Lovrincevic, M., Millenson, M. M., Neff, A. T., Ortel, T. L., Paschal, R., Shattil, S., Siddiqi, T., Smock, K. J., Soff, G., Wang, T.-F., Yee, G. C., Zakarija, A., McMillian, N., & Engh, A. M.
Venue
Journal of the National Comprehensive Cancer Network
Published
2015-09
Volume
13
Issue
9
Pages
1079-1095
ISSN
  • 1540-1405 (ISSN-L)
  • 1540-1413
OpenAlex
W2210532669
Cited by
218
References
3
FWCI
21.22
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cancer-Associated Venous Thromboembolic Disease, Version 1.2015. https://app.cochat.ai/papers/10.6004/jnccn.2015.0133
The paper
Streiff, M. B., Holmstrom, B., Ashrani, A., Bockenstedt, P. L., Chesney, C., Eby, C., Fanikos, J., Fenninger, R. B., Fogerty, A. E., Gao, S., Goldhaber, S. Z., Hendrie, P., Kuderer, N., Lee, A., Lee, J. T., Lovrincevic, M., Millenson, M. M., Neff, A. T., Ortel, T. L., . . . Engh, A. M. (2015). Cancer-Associated Venous Thromboembolic Disease, Version 1.2015. Journal of the National Comprehensive Cancer Network. https://doi.org/10.6004/jnccn.2015.0133

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.